Best Agrolife (539660) investor relations material

Executive summary

• Q1 FY27 saw resilient performance and revenue growth of 4% year-on-year to ₹396 crore, with profit after tax doubling to ₹41 crore, driven by margin expansion, operational efficiencies, and a shift to patented products.

• Despite delayed and uneven monsoon impacting demand, key patented products gained market acceptance, with new launches like Fluzam and Cubax Power Extra seeing increasing adoption.

• The company increased the share of patented products in branded sales to 64%-65%, reducing generics and focusing on higher-margin offerings.

• Focus on innovation, operational efficiency, and expanding market presence to drive sustainable value.

Financial highlights

• Revenue from operations reached ₹396 crore, up 4% year-on-year; gross profit rose 32% to ₹146 crore, with gross margin improving to 37% from 29%.

• EBITDA increased 70% year-on-year to ₹78 crore, with EBITDA margin expanding to 20% from 12%.

• PAT grew 104% year-on-year to ₹41 crore; PAT margin improved to 10% from 5%.

• Operating expenses rose 4.5% year-on-year to ₹92.97 crore.

• Diluted EPS: ₹8.42 in Q1 FY27 vs. ₹1.15 in Q1 FY26.

Outlook and guidance

• Management expects improved demand in Q2 as monsoon conditions normalize and sowing increases, with optimism for FY27 supported by new product adoption.

• Patent portfolio contribution to branded sales expected to remain 60%-70% in the near to medium term.

• Revenue CAGR targeted at 10%-15% over the next 3-4 years, with sustainable EBITDA margins of 13%-14%.

• Q2 anticipated to be strong; Q3 and Q4 performance will depend on rainfall and sales returns.